US 10253102
Antigen-binding proteins that activate the leptin receptor
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 10253102 (Antigen-binding proteins that activate the leptin receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61P, A61P15/00